DARKPOOL0.1.0
AFT-MKT Sign in
ZBIO
Zenas BioPharma, Inc.
NMS Equity
28.70
+0.12 (+0.42%)
52w low 13.50 44.60 high
48.9% of range

Financial Analysis

Annual
(USD) Dec 22Dec 23Dec 24Dec 25 Trend
Operating Cash Flow -65.65M-30.53M-119.67M-172.33M
Depreciation & Amort 78.00K113.00K137.00K56.00K
Capital Expenditure -2.20M-17.00K-131.00K-35.02M
Free Cash Flow -67.85M-30.55M-119.81M-207.35M
Investing Cash Flow -2.20M-17.00K-30.55M-251.89M
Financing Cash Flow 59.39M20.12M412.96M215.28M
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
+100.0%